首页> 美国卫生研究院文献>Cancer Medicine >Mortality and admission to intensive care units after febrile neutropenia in patients with cancer
【2h】

Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

机译:癌症患者发热性中性粒细胞减少症的死亡率和重症监护病房的入院

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Febrile neutropenia (FN) is a critical complication of chemotherapy associated with increased in‐hospital mortality. However, associations with increased mortality and intensive care unit (ICU) admissions during longer follow‐up are not established. Patients treated with standard first‐line chemotherapy for solid cancers at Rigshospitalet, Denmark in 2010‐2016 were included. Incidence rate ratios (IRR) of all‐cause, infectious and cardiovascular mortality, and ICU admissions after FN were analyzed by Poisson regression. Risk factors at the time of FN were analyzed in the subpopulation of patients with FN; all‐cause mortality was further stratified by the time periods 0‐30, 31‐365, and 366+ days after FN. We included 9018 patients with gastric (14.4%) and breast (13.1%) cancer being the most common, 51.2% had locally advanced or disseminated disease and the patients had a median Charlson Comorbidity Index score of 0 (interquartile range, 0‐0). During follow‐up, 845 (9.4%) experienced FN and 4483 (49.7%) died during 18 775 person‐years of follow‐up. After adjustment, FN was associated with increased risk of all‐cause mortality, infectious mortality, and ICU admissions with IRRs of 1.39 (95% CI, 1.24‐1.56), 1.94 (95% CI, 1.43‐2.62), and 2.28 (95% CI, 1.60‐3.24). Among those with FN, having a positive blood culture and low lymphocytes were associated with excess risk of death and ICU admissions (predominantly the first 30 days after FN), while elevated C‐reactive protein and low hemoglobin predicted mortality the first year after FN. The risk of death varied according to the time since FN; adjusted IRR per additional risk factor present for the time periods 0‐30, 31‐365, and 366+ days after FN were 2.00 (95% CI, 1.45‐2.75), 1.36 (95% CI, 1.17‐1.57), and 1.17 (95% CI, 0.98‐1.41). FN was associated with increased mortality and risk of ICU admissions. An objectively identifiable subgroup of patients among those with FN carried this excess risk.
机译:发热性中性粒细胞减少症(FN)是化疗中与住院死亡率增加相关的重要并发症。然而,长期随访中与死亡率增加和重症监护病房(ICU)入院的关联尚未建立。纳入2010-2016年在丹麦Rigshospitalet接受针对实体癌的标准一线化疗的患者。通过泊松回归分析全因,传染性和心血管性死亡率以及FN后ICU入院的发生率比(IRR)。在FN患者的亚群中分析了FN时的危险因素;在FN之后的0-30、31-365和366+天,进一步将全因死亡率分层。我们纳入了9018例最常见的胃癌(14.4%)和乳腺癌(13.1%)患者,51.2%的局部晚期或弥漫性疾病且患者的Charlson合并症指数中位数为0(四分位范围为0-0) 。在随访期间,在18775人-年的随访期间,有845名(9.4%)经历过FN,并且有4483名(49.7%)死亡。调整后,FN与全因死亡率,传染性死亡率和ICU入院风险增加相关,IRR为1.39(95%CI,1.24-1.56),1.94(95%CI,1.43-2.62)和2.28(95) %CI,1.60-3.24)。在FN患者中,血液培养阳性且淋巴细胞低与死亡和ICU入院的过多风险相关(主要是在FN后的前30天),而C反应蛋白升高和血红蛋白低则预示FN发生后第一年的死亡率。自FN以来的时间,死亡风险有所不同; FN发生后0-30、31-365和366+天的每个额外风险因子的调整后IRR为2.00(95%CI,1.45-2.75),1.36(95%CI,1.17-1.57)和1.17 (95%CI,0.98-1.41)。 FN与死亡率增加和ICU入院风险相关。 FN患者中一个客观可识别的患者亚组具有这种过度风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号